Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “X4 Pharmaceuticals, Inc.”

16 pharma patents match "X4 Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 16
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 16 pharmaceutical patents matching "X4 Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

16 results for “X4 Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 12377090

    Methods for treating neutropenia

    X4 Pharmaceuticals, Inc. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  2. US 12285424

    Methods for treating neutropenia

    X4 Pharmaceuticals, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  3. US 12115156

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  4. US 11780837

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted
  5. US 11672793

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  6. US 11357742

    Methods for treating cancer

    X4 Pharmaceuticals, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  7. US 11337969

    Methods for treating cancer

    X4 Pharmaceuticals, Inc. · Granted May 24, 2022 · Expires May 19, 2042

    granted
  8. US 11332470

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted May 17, 2022 · Expires May 12, 2042

    granted
  9. US 11306088

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  10. US 11219621

    Methods for treating immunodeficiency disease

    X4 Pharmaceuticals, Inc. · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted
  11. US 11045461

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  12. US 10988465

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  13. US 10953003

    Methods for treating cancer

    X4 Pharmaceuticals, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  14. US 10759796

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  15. US 10610527

    Methods for treating immunodeficiency disease

    X4 Pharmaceuticals, Inc. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  16. US 10548889

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted